NFKB1 and central nervous system cancer: The treatment of U251 glioma cells with emodin significantly decreased mRNA and protein expression levels of NF-KB-regulated expressions of syndecan-1, a surface heparan sulfate that proteoglycan presents in malignant glioma cells but not in normal brain specimens [40].